Discover
LSTA
Lisata Therapeutics, Inc.
1.70
1 x 1.08
1 x 4.50
bid
ask
-
0.04
2.30%
1 @ 04:00 PM
1.70 +0.00 (0.00%)
| Ytd | -8.60% | |
| 1y | -28.87% |
1.63
day range
1.76
0.99
52 week range
5.07
| Open | 1.71 | Prev Close | 1.74 | Low | 1.63 | High | 1.76 | Mkt Cap | 18.37M |
| Vol | 293.91K | Avg Vol | 286.27K | EPS | -1.64 | P/E | N/A | Forward P/E | -1.20 |
| Beta | 1.22 | Short Ratio | 1.79 | Inst. Own | 9.07% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 1.76 | 200-d Avg | 3.11 | 1yr Est | 14.00 |
| Income Statement | |||
| Operating Expenses | 3.99M | ||
| Research and Development Expense | 584.00K | ||
| Selling, General and Administrative Expense | 3.41M | ||
| Operating Income | -3.99M | ||
| Net Income | -2.93M | ||
| Net Income Common Stock | -2.93M | ||
| Net Income Common Stock (USD) | -2.93M | ||
| Consolidated Income | -2.93M | ||
| Earnings per Basic Share | -0.32 | ||
| Earnings per Basic Share (USD) | -0.32 | ||
| Earnings per Diluted Share | -0.32 | ||
| Earning Before Interest & Taxes (EBIT) | -2.93M | ||
| Earning Before Interest & Taxes (USD) | -2.93M | ||
| Weighted Average Shares | 9.11M | ||
| Weighted Average Shares Diluted | 9.11M | ||
| Balance Sheet | |||
| Cash and Equivalents | 10.44M | ||
| Cash and Equivalents (USD) | 10.44M | ||
| Current Assets | 11.01M | ||
| Property, Plant & Equipment Net | 14.00K | ||
| Total Assets | 11.03M | ||
| Current Liabilities | 2.99M | ||
| Total Liabilities | 3.04M | ||
| Accumulated Retained Earnings (Deficit) | -572.07M | ||
| Accumulated Other Comprehensive Income | -17.00K | ||
| Shareholders Equity | 8.24M | ||
| Shareholders Equity (USD) | 8.24M | ||
| Assets Non-Current | 14.00K | ||
| Liabilities Non-Current | 50.00K | ||
| Trade and Non-Trade Payables | 836.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.00K | ||
| Net Cash Flow from Financing | 29.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.62M | ||
| Issuance (Purchase) of Equity Shares | 29.00K | ||
| Net Cash Flow from Operations | -2.65M | ||
| Effect of Exchange Rate Changes on Cash | 3.00K | ||
| Share Based Compensation | 214.00K | ||